1-methyl-3-[2-[5-[[4-(oxan-4-yl)phenyl]methyl]-1,3-thiazol-2-yl]-3,4-dihydro-1H-isoquinolin-7-yl]-1,3-diazinan-2-one

C29H34N4O2S — CID 138571199

IUPAC1-methyl-3-[2-[5-[[4-(oxan-4-yl)phenyl]methyl]-1,3-thiazol-2-yl]-3,4-dihydro-1H-isoquinolin-7-yl]-1,3-diazinan-2-one
SMILESCN1CCCN(c2ccc3c(c2)CN(c2ncc(Cc4ccc(C5CCOCC5)cc4)s2)CC3)C1=O
InChIInChI=1S/C29H34N4O2S/c1-31-12-2-13-33(29(31)34)26-8-7-23-9-14-32(20-25(23)18-26)28-30-19-27(36-28)17-21-3-5-22(6-4-21)24-10-15-35-16-11-24/h3-8,18-19,24H,2,9-17,20H2,1H3
InChIKeyDVNOLKKGALSLJN-UHFFFAOYSA-N
MW502.68 g/mol
LogP5.45
Rot. Bonds5

About 1-methyl-3-[2-[5-[[4-(oxan-4-yl)phenyl]methyl]-1,3-thiazol-2-yl]-3,4-dihydro-1H-isoquinolin-7-yl]-1,3-diazinan-2-one

1-methyl-3-[2-[5-[[4-(oxan-4-yl)phenyl]methyl]-1,3-thiazol-2-yl]-3,4-dihydro-1H-isoquinolin-7-yl]-1,3-diazinan-2-one (PubChem CID 138571199) has the molecular formula C29H34N4O2S and a molecular weight of 502.68 g/mol. Its IUPAC name is 1-methyl-3-[2-[5-[[4-(oxan-4-yl)phenyl]methyl]-1,3-thiazol-2-yl]-3,4-dihydro-1H-isoquinolin-7-yl]-1,3-diazinan-2-one.

Molecular Properties

Compound Name1-methyl-3-[2-[5-[[4-(oxan-4-yl)phenyl]methyl]-1,3-thiazol-2-yl]-3,4-dihydro-1H-isoquinolin-7-yl]-1,3-diazinan-2-one
PubChem CID138571199
Molecular FormulaC29H34N4O2S
Molecular Weight502.68 g/mol
Exact Mass502.24
IUPAC Name1-methyl-3-[2-[5-[[4-(oxan-4-yl)phenyl]methyl]-1,3-thiazol-2-yl]-3,4-dihydro-1H-isoquinolin-7-yl]-1,3-diazinan-2-one
SMILESCN1CCCN(c2ccc3c(c2)CN(c2ncc(Cc4ccc(C5CCOCC5)cc4)s2)CC3)C1=O
InChIInChI=1S/C29H34N4O2S/c1-31-12-2-13-33(29(31)34)26-8-7-23-9-14-32(20-25(23)18-26)28-30-19-27(36-28)17-21-3-5-22(6-4-21)24-10-15-35-16-11-24/h3-8,18-19,24H,2,9-17,20H2,1H3
InChIKeyDVNOLKKGALSLJN-UHFFFAOYSA-N
XLogP5.45
TPSA48.91 Ų
H-Bond Donors
H-Bond Acceptors5
Rotatable Bonds5
Heavy Atoms36
Complexity—

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500502.68
LogP ≤ 55.45
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 105

Analyze 1-methyl-3-[2-[5-[[4-(oxan-4-yl)phenyl]methyl]-1,3-thiazol-2-yl]-3,4-dihydro-1H-isoquinolin-7-yl]-1,3-diazinan-2-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 1-methyl-3-[2-[5-[[4-(oxan-4-yl)phenyl]methyl]-1,3-thiazol-2-yl]-3,4-dihydro-1H-isoquinolin-7-yl]-1,3-diazinan-2-one?
The IUPAC name of 1-methyl-3-[2-[5-[[4-(oxan-4-yl)phenyl]methyl]-1,3-thiazol-2-yl]-3,4-dihydro-1H-isoquinolin-7-yl]-1,3-diazinan-2-one (CID 138571199) is 1-methyl-3-[2-[5-[[4-(oxan-4-yl)phenyl]methyl]-1,3-thiazol-2-yl]-3,4-dihydro-1H-isoquinolin-7-yl]-1,3-diazinan-2-one.
What is the SMILES notation for 1-methyl-3-[2-[5-[[4-(oxan-4-yl)phenyl]methyl]-1,3-thiazol-2-yl]-3,4-dihydro-1H-isoquinolin-7-yl]-1,3-diazinan-2-one?
The canonical SMILES for 1-methyl-3-[2-[5-[[4-(oxan-4-yl)phenyl]methyl]-1,3-thiazol-2-yl]-3,4-dihydro-1H-isoquinolin-7-yl]-1,3-diazinan-2-one is CN1CCCN(c2ccc3c(c2)CN(c2ncc(Cc4ccc(C5CCOCC5)cc4)s2)CC3)C1=O.
What is the InChIKey of 1-methyl-3-[2-[5-[[4-(oxan-4-yl)phenyl]methyl]-1,3-thiazol-2-yl]-3,4-dihydro-1H-isoquinolin-7-yl]-1,3-diazinan-2-one?
The InChIKey is DVNOLKKGALSLJN-UHFFFAOYSA-N. The full InChI is InChI=1S/C29H34N4O2S/c1-31-12-2-13-33(29(31)34)26-8-7-23-9-14-32(20-25(23)18-26)28-30-19-27(36-28)17-21-3-5-22(6-4-21)24-10-15-35-16-11-24/h3-8,18-19,24H,2,9-17,20H2,1H3.
What are the key properties of 1-methyl-3-[2-[5-[[4-(oxan-4-yl)phenyl]methyl]-1,3-thiazol-2-yl]-3,4-dihydro-1H-isoquinolin-7-yl]-1,3-diazinan-2-one?
1-methyl-3-[2-[5-[[4-(oxan-4-yl)phenyl]methyl]-1,3-thiazol-2-yl]-3,4-dihydro-1H-isoquinolin-7-yl]-1,3-diazinan-2-one has a molecular weight of 502.68 g/mol, XLogP of 5.45, 5 rotatable bonds, 0 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for 1-methyl-3-[2-[5-[[4-(oxan-4-yl)phenyl]methyl]-1,3-thiazol-2-yl]-3,4-dihydro-1H-isoquinolin-7-yl]-1,3-diazinan-2-one is sourced from PubChem (CID 138571199), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).